These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33531899)

  • 1. Osteocalcin Alleviates Nonalcoholic Fatty Liver Disease in Mice through GPRC6A.
    Zhang M; Nie X; Yuan Y; Wang Y; Ma X; Yin J; Bao Y
    Int J Endocrinol; 2021; 2021():9178616. PubMed ID: 33531899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocyte-specific GPRC6A ablation promotes diet-induced obesity by inhibiting lipolysis.
    Mukai S; Mizokami A; Otani T; Sano T; Matsuda M; Chishaki S; Gao J; Kawakubo-Yasukochi T; Tang R; Kanematsu T; Takeuchi H; Jimi E; Hirata M
    J Biol Chem; 2021; 296():100274. PubMed ID: 33428938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK.
    Du J; Zhang M; Lu J; Zhang X; Xiong Q; Xu Y; Bao Y; Jia W
    Endocrine; 2016 Sep; 53(3):701-9. PubMed ID: 26994931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newly identified peptide hormone inhibits intestinal fat absorption and improves NAFLD through its receptor GPRC6A.
    Teng B; Huang C; Cheng CL; Udduttula A; Yu XF; Liu C; Li J; Yao ZY; Long J; Miao LF; Zou C; Chu J; Zhang JV; Ren PG
    J Hepatol; 2020 Aug; 73(2):383-393. PubMed ID: 32147363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteocalcin and Non-Alcoholic Fatty Liver Disease: Lessons From Two Population-Based Cohorts and Animal Models.
    Xia M; Rong S; Zhu X; Yan H; Chang X; Sun X; Zeng H; Li X; Zhang L; Chen L; Wu L; Ma H; Hu Y; He W; Gao J; Pan B; Hu X; Lin H; Bian H; Gao X
    J Bone Miner Res; 2021 Apr; 36(4):712-728. PubMed ID: 33270924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and skeletal homeostasis are maintained in full locus GPRC6A knockout mice.
    Jørgensen CV; Gasparini SJ; Tu J; Zhou H; Seibel MJ; Bräuner-Osborne H
    Sci Rep; 2019 Apr; 9(1):5995. PubMed ID: 30979912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine GPRC6A Mediates Cellular Responses to L-Amino Acids, but Not Osteocalcin Variants.
    Rueda P; Harley E; Lu Y; Stewart GD; Fabb S; Diepenhorst N; Cremers B; Rouillon MH; Wehrle I; Geant A; Lamarche G; Leach K; Charman WN; Christopoulos A; Summers RJ; Sexton PM; Langmead CJ
    PLoS One; 2016; 11(1):e0146846. PubMed ID: 26785252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Explaining Divergent Observations Regarding Osteocalcin/GPRC6A Endocrine Signaling.
    Pi M; Nishimoto SK; Darryl Quarles L
    Endocrinology; 2021 Apr; 162(4):. PubMed ID: 33474566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of osteocalcin in lipid metabolism in adipose tissue and liver.
    Otani T; Mizokami A; Kawakubo-Yasukochi T; Takeuchi H; Inai T; Hirata M
    Adv Biol Regul; 2020 Dec; 78():100752. PubMed ID: 32992234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity.
    Sachithanandan N; Fam BC; Fynch S; Dzamko N; Watt MJ; Wormald S; Honeyman J; Galic S; Proietto J; Andrikopoulos S; Hevener AL; Kay TW; Steinberg GR
    Hepatology; 2010 Nov; 52(5):1632-42. PubMed ID: 20799351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway.
    Zhang XL; Wang YN; Ma LY; Liu ZS; Ye F; Yang JH
    Acta Pharmacol Sin; 2020 Mar; 41(3):383-393. PubMed ID: 31659239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T Cell Factor 7 (TCF7)/TCF1 Feedback Controls Osteocalcin Signaling in Brown Adipocytes Independent of the Wnt/β-Catenin Pathway.
    Li Q; Hua Y; Yang Y; He X; Zhu W; Wang J; Gan X
    Mol Cell Biol; 2018 Apr; 38(7):. PubMed ID: 29358218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for Osteocalcin Binding and Activation of GPRC6A in β-Cells.
    Pi M; Kapoor K; Ye R; Nishimoto SK; Smith JC; Baudry J; Quarles LD
    Endocrinology; 2016 May; 157(5):1866-80. PubMed ID: 27007074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncarboxylated osteocalcin stimulates 25-hydroxy vitamin D production in Leydig cell line through a GPRC6a-dependent pathway.
    De Toni L; De Filippis V; Tescari S; Ferigo M; Ferlin A; Scattolini V; Avogaro A; Vettor R; Foresta C
    Endocrinology; 2014 Nov; 155(11):4266-74. PubMed ID: 25093461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPRC6A: Jack of all metabolism (or master of none).
    Pi M; Nishimoto SK; Quarles LD
    Mol Metab; 2017 Feb; 6(2):185-193. PubMed ID: 28180060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiligand specificity and wide tissue expression of GPRC6A reveals new endocrine networks.
    Pi M; Quarles LD
    Endocrinology; 2012 May; 153(5):2062-9. PubMed ID: 22374969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
    Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
    Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPRC6A mediates responses to osteocalcin in β-cells in vitro and pancreas in vivo.
    Pi M; Wu Y; Quarles LD
    J Bone Miner Res; 2011 Jul; 26(7):1680-3. PubMed ID: 21425331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased susceptibility to diet-induced obesity in GPRC6A receptor knockout mice.
    Clemmensen C; Smajilovic S; Madsen AN; Klein AB; Holst B; Bräuner-Osborne H
    J Endocrinol; 2013 May; 217(2):151-60. PubMed ID: 23428581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-specific deletion of the signal transducer and activator of transcription 5 gene aggravates fatty liver in response to a high-fat diet in mice.
    Baik M; Nam YS; Piao MY; Kang HJ; Park SJ; Lee JH
    J Nutr Biochem; 2016 Mar; 29():56-63. PubMed ID: 26895665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.